Skip to Main Content

The pace of innovation in wearable technology has never been faster. As often as once a year, major brands debut new devices, offering consumers sleeker and faster hardware and updated software.

While consumers may get excited about the latest bells and whistles, these product launches generally leave the clinical care and research communities in the cold. This is unfortunate for two reasons: it’s doesn’t advance health care, and it’s a missed business opportunity for companies that make wearables.


The pharmaceutical industry is an increasingly interested buyer for these devices. What was once a novelty for trials and studies is now approaching common practice.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • An interesting read. Appearance, battery life, and interoperability (through varying approach) are indeed important. With more validated virtual care use cases and platform / cloud service readiness, #quantifyself could be the value driver for clinical trials and beyond.

Comments are closed.